Study Type
Narrative review
Comprehensive biologic reconstruction overview
Why This Matters
Limb salvage is now possible in >90% of bone tumor patients, but long-term failure rates of prosthetic and allograft reconstructions remain a major challenge
This study revisits:
Biological (living bone) reconstruction as a durable alternative
Key Findings
1. Autograft = Biologic + Long-Term Durable Option
Provides:
Osteoconduction
Osteoinduction
Osteogenesis
Unlike allografts → no immunogenicity
2. Trade-off: Short-Term Complications vs Long-Term Survival
Autografts:
Higher early complication rates
Better long-term durability
Endoprosthesis:
Early stability
Increasing failure over time
Core dilemma in oncologic reconstruction
3. Vascularized Grafts Are the Most Powerful Option
Up to >90% osteocyte survival after transfer
True biologic remodeling
Closest to “normal bone healing”
4. Healing Takes Time
Union may take:
3–13 months
No immediate weight-bearing advantage
5. Fibula = Workhorse Graft
Indicated for:
Large defects (>12 cm)
Can hypertrophy and remodel over time
Most commonly used vascularized graft
6. High Complication Rates Remain
Nonunion
Fracture
Infection
Donor-site morbidity
Complication rates up to 40–50% in some techniques
7. Distraction Osteogenesis Has Limitations in Oncology
Long treatment duration
External fixation issues
Chemotherapy interference
Limits widespread use
8. Pediatric Advantage: Growth Potential
Biological reconstructions:
Allow continued growth
Critical in skeletally immature patients
Clinical Implications
Reconstruction choice = balance between:
Durability
Complication risk
Functional outcome
No single best technique
Limitations
Mostly heterogeneous data
Lack of high-level comparative studies
Technique-dependent outcomes
Rico Insight
This paper highlights a fundamental truth: “The best reconstruction is not the strongest one today, but the one that survives 10–20 years.”
Biologic reconstruction is not about perfection. → it is about longevity and adaptability
Clinical Pearls
Vascularized graft = highest biologic potential
Fibula = most versatile graft
Autograft = best for long-term durability
Expect complications early, stability later
Decision Box
Young patient + long life expectancy
→ Prefer biologic reconstruction
Large defect (>12 cm)
→ Consider vascularized fibula
Need for immediate stability
→ Consider prosthetic option
High infection risk
→ Favor biologic approach
Poor host / comorbidities
→ Avoid complex biologic reconstruction